{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["The first affiliated hospital of USTC"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1179664"],"long_description":["We previously reported that LukS-PV, a component of Panton-Valentine interleukin (PVL), has anti-leukaemic activity, inducing differentiation, increasing apoptosis and inhibiting proliferation of acute myeloid leukaemia (AML) cells. In addition, our study showed that LukS-PV could inhibit the progression of hepatocellular carcinoma (HCC) by targeting C5aR. To investigate the biological mechanisms involved, we performed RNA-seq on PBS/LukS-PV-treated HCC cells to search for important downstream regulators."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"RNA-seq of HepG2 cells after treatment with PBS or LukS-PV","dates":{"last_updated":"2024-10-31","first_public":"2024-10-31"},"accession":"PRJNA1179664","cross_references":{}}